Correlation Between NYSE Composite and Mydecine Innovations
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Mydecine Innovations Group, you can compare the effects of market volatilities on NYSE Composite and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Mydecine Innovations.
Diversification Opportunities for NYSE Composite and Mydecine Innovations
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and Mydecine is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of NYSE Composite i.e., NYSE Composite and Mydecine Innovations go up and down completely randomly.
Pair Corralation between NYSE Composite and Mydecine Innovations
Assuming the 90 days trading horizon NYSE Composite is expected to generate 129.52 times less return on investment than Mydecine Innovations. But when comparing it to its historical volatility, NYSE Composite is 109.33 times less risky than Mydecine Innovations. It trades about 0.1 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 7.80 in Mydecine Innovations Group on September 28, 2024 and sell it today you would lose (7.52) from holding Mydecine Innovations Group or give up 96.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Mydecine Innovations Group
Performance |
Timeline |
NYSE Composite and Mydecine Innovations Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Mydecine Innovations Group
Pair trading matchups for Mydecine Innovations
Pair Trading with NYSE Composite and Mydecine Innovations
The main advantage of trading using opposite NYSE Composite and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.NYSE Composite vs. Ziff Davis | NYSE Composite vs. Zijin Mining Group | NYSE Composite vs. Cheniere Energy Partners | NYSE Composite vs. Perseus Mining Limited |
Mydecine Innovations vs. Genesis Electronics Group | Mydecine Innovations vs. Nextmart | Mydecine Innovations vs. Emergent Health Corp | Mydecine Innovations vs. Goff Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |